NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients
1 clinical trials · Condition
◉ Watch NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients
| Record | Firm | Date |
|---|---|---|
| Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors (NCT02869217) | University Health Network, Toronto | 2016-09-01 |
Track NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients automatically
Every clearance here is in the API, with alerts when new ones post.